Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_1
2
67%
Ph not_applicable
1
33%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (66.7%)
N/A1 (33.3%)

Trials by Status

terminated133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities

NCT00906737
terminatedphase_1

Targeted Lower Extremity Joint Training

NCT00765544
completedphase_1

Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis

NCT00872053

Clinical Trials (3)

Showing 3 of 3 trials
NCT00906737Not Applicable

Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities

Completed
NCT00765544Phase 1

Targeted Lower Extremity Joint Training

Terminated
NCT00872053Phase 1

Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3